At Rivercyte, we combine years of experience in deformability cytometry, deep learning, hardware, and software development to establish a novel technology for rapid physical phenotyping of cells. Our core technology is based on a microfluidic chip through which cells flow and deform. Using high-speed microscopy, an image of each cell is captured and analyzed with AI-based software. Ultimately, our technology will be an invaluable tool for detecting anomalies in cell samples and for automating routine analytical procedures in life science and medicine.
| Website | http://www.rivercyte.com |
| Employees | 4 (3 on RocketReach) |
| Founded | 2022 |
| Address | Henkestraße 91, Erlangen, Bavaria 91052, DE |
| Industry | Biotechnology Research |
| Keywords | Cell Analysis, Microfluidics, Deep Learning, Single Cell Analysis, Lab On A Chip, Cellular Imaging, Biotechnology, Fluid Mechanics, High Throughput Screening, Medical Technology, Hardware Development, Software Development, Biomedical Engineering, Drug Discovery, Diagnostic Tools |
Looking for a particular Rivercyte employee's phone or email?
Martin Kräter is the CEO at Rivercyte GmbH of Rivercyte.
3 people are employed at Rivercyte.
Rivercyte is based in Erlangen, Bavaria.